Overview
Cecilia Calleja-Munoz practices practicing medicine in Madrid, Spain.
Ms. Calleja-Munoz is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Chronic Graft Versus Host Disease (cGvHD), Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), and Small Lymphocytic Lymphoma (SLL).
She is actively involved in clinical research, co-authoring 57 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Cecilia Calleja-Munoz
Is Cecilia Calleja-Munoz a top-rated expert for Chronic Graft Versus Host Disease (cGvHD)?
MediFind is an objective health platform that identifies experts based on real-world data. Cecilia Calleja-Munoz is classified as an Advanced expert for Chronic Graft Versus Host Disease (cGvHD), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Cecilia Calleja-Munoz participate in research or clinical trials?
Yes. Cecilia Calleja-Munoz has published 57 articles and abstracts on conditions like Chronic Graft Versus Host Disease (cGvHD). You can view a list of Cecilia Calleja-Munoz's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Chronic Graft Versus Host Disease (cGvHD)Ms. Calleja-Munoz isAdvanced. Learn about Chronic Graft Versus Host Disease (cGvHD).
- Experienced
- Acute Respiratory Distress Syndrome (ARDS)Ms. Calleja-Munoz isExperienced. Learn about Acute Respiratory Distress Syndrome (ARDS).
- ArthritisMs. Calleja-Munoz isExperienced. Learn about Arthritis.
- Chronic B-Cell Leukemia (CBCL)Ms. Calleja-Munoz isExperienced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Ms. Calleja-Munoz isExperienced. Learn about Chronic Lymphocytic Leukemia (CLL).
- Chronic Myelogenous Leukemia (CML)Ms. Calleja-Munoz isExperienced. Learn about Chronic Myelogenous Leukemia (CML).
- Chronic Obstructive Pulmonary Disease (COPD)Ms. Calleja-Munoz isExperienced. Learn about Chronic Obstructive Pulmonary Disease (COPD).
- Chronic T-Cell Leukemia (CTCL)Ms. Calleja-Munoz isExperienced. Learn about Chronic T-Cell Leukemia (CTCL).
- COVID-19Ms. Calleja-Munoz isExperienced. Learn about COVID-19.
- Cutaneous Lupus Erythematosus (CLE)Ms. Calleja-Munoz isExperienced. Learn about Cutaneous Lupus Erythematosus (CLE).
- Graft Versus Host Disease (GvHD)Ms. Calleja-Munoz isExperienced. Learn about Graft Versus Host Disease (GvHD).
- LeukemiaMs. Calleja-Munoz isExperienced. Learn about Leukemia.
- Multiple MyelomaMs. Calleja-Munoz isExperienced. Learn about Multiple Myeloma.
- Neurotoxicity SyndromesMs. Calleja-Munoz isExperienced. Learn about Neurotoxicity Syndromes.
- Prolymphocytic LeukemiaMs. Calleja-Munoz isExperienced. Learn about Prolymphocytic Leukemia.
- Rheumatoid Arthritis (RA)Ms. Calleja-Munoz isExperienced. Learn about Rheumatoid Arthritis (RA).
- SepsisMs. Calleja-Munoz isExperienced. Learn about Sepsis.
- Severe Acute Respiratory Syndrome (SARS)Ms. Calleja-Munoz isExperienced. Learn about Severe Acute Respiratory Syndrome (SARS).
- Small Lymphocytic Lymphoma (SLL)Ms. Calleja-Munoz isExperienced. Learn about Small Lymphocytic Lymphoma (SLL).
- VasoconstrictionMs. Calleja-Munoz isExperienced. Learn about Vasoconstriction.